Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

por Kim, S T, Banks, K C, Pectasides, E, Kim, S Y, Kim, K, Lanman, R B, Talasaz, A, An, J, Choi, M G, Lee, J H, Sohn, T S, Bae, J M, Kim, S, Park, S H, Park, J O, Park, Y S, Lim, H Y, Kim, N K D, Park, W, Lee, H, Bass, A J, Kim, K, Kang, W K, Lee, J
Publicado 2018

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma

por Goedegebuure, R.S.A., Harrasser, M., de Klerk, L.K., van Schooten, T.S., van Grieken, N.C.T., Eken, M., Grifhorst, M.S., Pocorni, N., Jordanova, E.S., van Berge Henegouwen, M.I., Pouw, R.E., Verheul, H.M.W., van der Vliet, J.J., van Laarhoven, H.W.M., Thijssen, V.L.J.L, Bass, A.J., De Gruijl, T.D., Derks, S.
Publicado 2021